Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma

NCT06198465 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Adebrelimab
Esophageal Cancer
Perioperative Period

Interventions

DRUG: adebrelimab,Paclitaxel,Lobaplatin,Fluorouracil

Sponsor

Xijing Hospital